Pulmonary hypertension due to left heart diseases

JL Vachiéry, Y Adir, JA Barberà, H Champion… - Journal of the American …, 2013 - jacc.org
Pulmonary hypertension (PH), a common complication of left heart diseases (LHD), negatively
impacts symptoms, exercise capacity, and outcome. Although the true prevalence of PH-…

Pulmonary hypertension in chronic lung diseases

W Seeger, Y Adir, JA Barberà, H Champion… - Journal of the American …, 2013 - jacc.org
Chronic obstructive lung disease (COPD) and diffuse parenchymal lung diseases (DPLD),
including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high …

Palliative care in interstitial lung disease: living well

…, AM Russell, S Bajwah, K Lindell, Y Adir… - The Lancet …, 2017 - thelancet.com
Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

[HTML][HTML] Type 2 inflammation in asthma and other airway diseases

J Maspero, Y Adir, M Al-Ahmad… - ERJ Open …, 2022 - Eur Respiratory Soc
… Jorge Maspero, Yochai Adir, Mona Al-Ahmad, Carlos A. Celis-Preciado, Federico D. Colodenco,
… Conflict of interest: Y. Adir reports personal fees from Teva and Sanofi, and grants and …

Asthma and COVID-19: an update

Y Adir, W Saliba, A Beurnier… - European Respiratory …, 2021 - Eur Respiratory Soc
As the world faces the coronavirus disease 2019 (COVID-19) pandemic due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, concerns have been raised …

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

…, N Berkman, G Fink, D Shitrit, Y Adir… - The Lancet …, 2023 - thelancet.com
Background Tezepelumab is a human monoclonal antibody that blocks thymic stromal
lymphopoietin. The drug has been tested previously in the phase 3 NAVIGATOR (NCT03347279) …

Modification of in Vivo and in Vitro TNF-α, IL-1, and IL-6 Secretion by Circulating Monocytes During Hyperbaric Oxygen Treatment in Patients with Perianal Crohn's …

G Weisz, A Lavy, Y Adir, Y Melamed, D Rubin… - Journal of clinical …, 1997 - Springer
Abstract Treatment of perianal inflammatory lesions in Crohn's disease (CD) is unsatisfactory
and novel treatment modalities are pursued. We have recently reported a good clinical …

Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension

…, G Simonneau, D Montani, M Humbert, Y Adir… - Circulation, 2018 - Am Heart Assoc
… *Drs Adir and Sitbon contributed equally and are joint last … *Drs Adir and Sitbon contributed
equally and are joint last … *Drs Adir and Sitbon contributed equally and are joint last authors. …

Swimming-induced pulmonary edema: clinical presentation and serial lung function

Y Adir, A Shupak, A Gil, N Peled, Y Keynan… - Chest, 2004 - Elsevier
Background: Acute pulmonary edema has been noted in swimmers and divers, and has
been termed swimming-induced pulmonary edema (SIPE). The mechanisms and …

Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a …

…, HA Liebman, M Shteinberg, Y Adir… - … of Thrombosis and …, 2016 - Wiley Online Library
Essentials We performed a pooled analysis of 926 patients with cancer‐associated incidental
pulmonary embolism (IPE). Vitamin K antagonists (VKA) are associated with a higher risk …